In contrast, low-to-neutral risk carriers exhibited DMGs linked to signaling cascades, metabolic pathways, and Type 2 diabetes-related mechanisms such as beta cell function and insulin signaling.<h4>Conclusion</h4>These findings indicate that heterogeneity in T1D pathogenetic mechanisms based on HLA background may influence disease development. Here, INS is linked to type 1 diabetes mellitus.